CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$5.93

Daily low

$5.44

Price at open

52 Week High

$14.60

52 Week Low

$3.78

Market cap

274.1M

Dividend yield

0.00%

Volume

28,793

Avg. volume

969,754

P/E ratio

-4.09

Candel Therapeutics News